Blood Test for Detecting Endometriosis in Women With Symptoms
Tests a blood-based test to detect endometriosis in symptomatic women aged 18 to 49.
Plain-language title generated from the registry record
Registry title: HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women
Key facts
- Where
- Hong Kong, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 49 years old?
Source: NCT07006987, who can take part
Where in China
- Department of Obstetrics & Gynaecology The Chinese University of Hong KongHong Kong, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Chinese University of Hong Kong
- Trial code
- NCT07006987
- Record updated
- 3 December 2025
- Original description
Endometriosis (EMS) is a common gynecological disease that affects 176 million girls and women globally. EMS affects 5-10% of women and adolescents within the reproductive age range of 15-49 years, and for those facing infertility, this figure may climb up to 50%. EMS can start at the first menstrual period and last until menopause. Shockingly, between 50% and 80% of women grappling with pelvic pain are found to have EMS. The formation of scar tissue (adhesions, fibrosis) within the pelvis and other parts of the body can cause severe pain and lead to infertility.Read full original descriptionShow less
Clinical Study for HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women of Ages 18-49 Years Considering Laparoscopy
Endometriosis (EMS) is a common gynecological disease that affects 176 million girls and women globally. EMS affects 5-10% of women and adolescents within the reproductive age range of 15-49 years, and for those facing infertility, this figure may climb up to 50%. EMS can start at the first menstrual period and last until menopause. Shockingly, between 50% and 80% of women grappling with pelvic pain are found to have EMS. The formation of scar tissue (adhesions, fibrosis) within the pelvis and other parts of the body can cause severe pain and lead to infertility.
Inclusion: Females aged 18 to 49 with mild to severe symptoms of pelvic pain and/or abnormal bleeding; Diagnostic laparoscopy is scheduled with histology on any visually suspected endometriosis, and all reports (surgical and pathology) to confirm a positive result. If no visually suspicious endometriotic lesions are seen, biopsies from random areas during the laparoscopy procedure to confirm a negative histopathology result; Blood drawn during secretory or proliferative phase of the menstrual cycle; Provide written informed consent to participate in the study and provide medical history on medications.
Exclusion: Patients who are unable or do not undergo laparoscopic surgery; Patients with cancer and/or undergoing chemotherapy and/or radiotherapy; Patients who object to medical history collection and data requests; Patients participating in additional interventional clinical studies; Pregnant, lactating, or subjects who are not healthy enough for blood donation; Blood drawn during menses or ovulation phase of menstrual cycle; Females who are post-menopausa.